Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1595888 NEW YORK, NY
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,578,774
-$49,321,531 QoQ
Shares Held
11,231
-90.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#455
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Jun 30, 2026
CallValue
$119,711,930
CallShares
241,000
PutValue
$29,903,146
PutShares
60,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names. VRTX ranks #34 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in VRTX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,903,146 60,200
2026-06-30 $119,711,930 241,000
2026-06-30 $5,578,774 11,231
2026-03-31 $54,900,305 122,946
2026-03-31 $68,097,350 152,500
2026-03-31 $64,882,262 145,300
2025-12-31 $51,275,016 113,100
2025-12-31 $55,219,248 121,800
2025-12-31 $5,098,485 11,246
2025-09-30 $56,787,800 145,000
2025-09-30 $20,991,904 53,600
2025-09-30 $97,231,287 248,267
2025-06-30 $29,472,240 66,200
2025-06-30 $41,893,320 94,100
2025-03-31 $21,768,418 44,900
2025-03-31 $42,227,822 87,100
2025-03-31 $7,276,177 15,008
2024-12-31 $29,437,370 73,100
2024-12-31 $58,673,390 145,700
2024-12-31 $5,860,895 14,554
2024-09-30 $13,859,384 29,800
2024-09-30 $49,949,592 107,400
2024-09-30 $25,203,614 54,192
2024-06-30 $142,334,327 303,666
2024-03-31 $59,611,569 142,608
2023-12-31 $70,700,798 173,759
2023-09-30 $20,983,674 60,343
2023-06-30 $10,020,284 28,474
2023-03-31 $6,849,306 21,739
2022-12-31 $6,650,313 23,029
2022-09-30 $9,568,138 33,046
2022-06-30 $6,389,869 22,676
2022-03-31 $4,416,656 16,924
2022-03-31 $53,237,880 204,000
2022-03-31 $57,282,915 219,500
2021-12-31 $14,508,531 66,068
2021-12-31 $54,592,560 248,600
2021-12-31 $50,024,880 227,800
2021-09-30 $43,515,461 239,900
2021-09-30 $24,532,452 135,247
2021-09-30 $31,670,694 174,600
2021-06-30 $35,990,955 178,500
2021-06-30 $35,142,899 174,294
2021-06-30 $48,371,037 239,900
2021-03-31 $23,891,470 111,180
2021-03-31 $48,221,316 224,400
2021-03-31 $38,357,865 178,500
2020-12-31 $26,351,910 111,500
2020-12-31 $15,574,806 65,900
2020-12-31 $24,303,550 102,833

Report a Problem

Category
Description
Email (optional, for follow-up)